Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases (2022)
- Authors:
- USP affiliated authors: BORBA NETO, EDUARDO FERREIRA - FM ; SARTORI, ANA MARLI CHRISTOVAM - FM ; ANTONANGELO, LEILA - FM ; SILVA, CLOVIS ARTUR ALMEIDA DA - FM ; BONFA, ELOISA SILVA DUTRA DE OLIVEIRA - FM
- Unidade: FM
- DOI: 10.1016/j.jvacx.2021.100131
- Subjects: IMUNOGENICIDADE DA VACINA; DOENÇAS AUTOIMUNES; BRASIL
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Vaccine: x
- ISSN: 2590-1362
- Volume/Número/Paginação/Ano: v. 10, article ID 100131, 4p, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
AIKAWA, Nadia Emi et al. Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases. Vaccine: x, v. 10, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jvacx.2021.100131. Acesso em: 19 fev. 2026. -
APA
Aikawa, N. E., Balbi, V. A., Borba Neto, E. F., Tonacio, A. C., Sallum, A. M. E., Campos, L. M. A., et al. (2022). Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases. Vaccine: x, 10. doi:10.1016/j.jvacx.2021.100131 -
NLM
Aikawa NE, Balbi VA, Borba Neto EF, Tonacio AC, Sallum AME, Campos LMA, Sartori AMC, Antonangelo L, Silva CAA da, Bonfa ESD de O. Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases [Internet]. Vaccine: x. 2022 ; 10[citado 2026 fev. 19 ] Available from: https://doi.org/10.1016/j.jvacx.2021.100131 -
Vancouver
Aikawa NE, Balbi VA, Borba Neto EF, Tonacio AC, Sallum AME, Campos LMA, Sartori AMC, Antonangelo L, Silva CAA da, Bonfa ESD de O. Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases [Internet]. Vaccine: x. 2022 ; 10[citado 2026 fev. 19 ] Available from: https://doi.org/10.1016/j.jvacx.2021.100131 - Short-term Accrual 2019 European League Against Rheumatism/American College of Rheumatology Domains and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage in Lupus Patients With and Without Nephritis at Disease Onset
- First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR)
- 2019-EULAR/ACR classification criteria domains at diagnosis: predictive factors of long-term damage in systemic lupus erythematosus
- Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome
- Complete urological evaluation including sperm DNA fragmentation in male systemic lupus erythematosus patients
- Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort
- Clinical features, damage accrual, and survival in patients with familial systemic lupus erythematosus: data from a multi-ethnic, multinational Latin American lupus cohort
- Anti-Lipoprotein Lipase Antibodies in Patients with Hypertriglyceridemia without Associated Autoimmune Disease
- Effect of Antimalarials over the Different Domains of the Damage INDEX in Latin American SLE Patients
- Dieta e aspectos nutricionais no lúpus eritematoso sistêmico
Informações sobre o DOI: 10.1016/j.jvacx.2021.100131 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
